PMCID: PMC6895888 Remvig L, Duhn PH, Ullman S, Kobayasi T, Hansen B, Juul-Kristensen B, Jurvelin JS, Arokoski J
Exp Clin Endocrinol Diabetes Horowitz M, Rayner CK, Marathe CS, Wu T, Jones KL (2020) Glucagon-like peptide-1 receptor agonists and the appropriate measurement of gastric emptying
For now, it is recommended that you continue to take it if you have Barretts
The term shows up across social media feeds and telehealth platforms alike
These medications work by slowing how the stomach empties and making people feel fuller, which can lead to eating smaller portions and cutting down on cravings